Hangzhou Biotest Biotech Co.,Ltd. Stock
Equities
688767
CNE1000050H0
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.87 CNY | +3.76% | +7.79% | +1.98% |
Sales 2022 | 1.9B 263M | Sales 2023 | 442M 61.2M | Capitalization | 3.23B 447M |
---|---|---|---|---|---|
Net income 2022 | 774M 107M | Net income 2023 | 107M 14.81M | EV / Sales 2022 | 1.52 x |
Net cash position 2022 | 2.03B 281M | Net cash position 2023 | 1.9B 264M | EV / Sales 2023 | 3 x |
P/E ratio 2022 |
6.37
x | P/E ratio 2023 |
30.3
x | Employees | 730 |
Yield 2022 |
4.76% | Yield 2023 |
-
| Free-Float | 33.12% |
1 day | +3.76% | ||
1 week | +7.79% | ||
Current month | +7.79% | ||
1 month | +19.79% | ||
3 months | +22.02% | ||
6 months | +1.38% | ||
Current year | +1.98% |
Managers | Title | Age | Since |
---|---|---|---|
Shu Jiang Wu
CEO | Chief Executive Officer | 47 | 10-01-31 |
Miao Miao Yu
DFI | Director of Finance/CFO | 43 | 15-12-31 |
Dong Chen
CTO | Chief Tech/Sci/R&D Officer | 28 | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yin Long Chen
CHM | Chairman | 62 | 15-09-27 |
Shu Jiang Wu
CEO | Chief Executive Officer | 47 | 10-01-31 |
Yu Jie Chen
BRD | Director/Board Member | 34 | 15-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 12 M€ | -16.71% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 30.87 | +3.76% | 1,002,514 |
24-05-08 | 29.75 | -0.70% | 649,816 |
24-05-07 | 29.96 | +1.77% | 809,050 |
24-05-06 | 29.44 | +2.79% | 990,203 |
End-of-day quote Shanghai S.E., May 08, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+1.98% | 456M | |
-0.30% | 12.64B | |
-1.64% | 8.37B | |
+0.13% | 5.37B | |
+22.42% | 5.26B | |
-0.09% | 4.58B | |
-52.84% | 3.16B | |
+20.02% | 2.89B | |
-8.58% | 2.22B | |
-2.45% | 1.91B |
- Stock Market
- Equities
- 688767 Stock